文献速递慢病防控与筛查卫生政策与健康促进

大麻使用与中青年美国成人全因及特定原因死亡率的关联

Association of Cannabis Use With All-Cause and Cause-Specific Mortality Among Younger- and Middle-Aged U.S. Adults.
PubMed 文献 · Am J Prev Med · 2020-11-18

研究基于2005-2014年NHANES的14,818名20-59岁无心血管病或癌症的成人,随访至2015年底。调整混杂因素后,曾使用大麻与心血管病死亡风险显著升高相关(HR=2.29,95%CI=1.10,4.78),尤其18岁前起始使用者(HR=3.00,95%CI=1.41,6.38);全因死亡和癌症死亡关联无统计学意义。

要点

  • 曾使用大麻与心血管病死亡风险升高相关(HR=2.29)。
  • 18岁前起始使用大麻者心血管病死亡风险更高(HR=3.00)。
  • 大麻使用与全因死亡和癌症死亡无显著关联。

核心结论

  • 大麻使用与美国中青年成人心血管病死亡风险显著升高相关,尤其在18岁前起始使用者中。

研究设计与样本

  • 研究纳入2005-2014年NHANES中14,818名20-59岁、基线无心血管病或癌症的成人,随访至2015年12月31日。

主要发现

  • 随访86,453人年期间共发生304例死亡,其中心血管病死亡39例,癌症死亡79例。
  • 调整混杂因素后,曾使用大麻者全因死亡HR=1.14(95%CI=0.81,1.59),心血管病死亡HR=2.29(95%CI=1.10,4.78),癌症死亡HR=0.67(95%CI=0.40,1.14)。
  • 18岁及以上首次使用大麻者心血管病死亡HR=1.65(95%CI=0.57,4.89),18岁前首次使用者为HR=3.00(95%CI=1.41,6.38)。

临床怎么用

  • 在预防医学与公共卫生实践中,应关注大麻使用者的心血管病风险,尤其询问首次使用年龄。
  • 对18岁前起始使用大麻的个体,可考虑加强心血管健康监测与健康教育。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cannabis is frequently used and increasingly legalized in the U.S., and 27.7 million Americans aged ≥12 years are currently using cannabis. However, the public health effects of cannabis use in the general population remain unclear. This study examines the associations of cannabis use with all-cause and cause-specific mortality in U.S. adults. METHODS: The study included 14,818 adults (aged 20-59 years) who participated in the National Health and Nutrition Examination Survey from 2005 to 2014 and were free of cardiovascular disease or cancer at baseline. Survey participants were linked to mortality records through December 31, 2015. The outcomes included all-cause mortality, cardiovascular disease mortality, and cancer mortality. All statistical analyses were conducted in 2019. RESULTS: During 86,453 person-years of observation, 304 deaths occurred, including 39 deaths from cardiovascular disease and 79 deaths from cancer. After adjustment for a variety of potential confounders, the hazard ratios for all-cause mortality, cardiovascular disease mortality, and cancer mortality among cannabis ever users, compared with the ratios among nonusers, were 1.14 (95% CI=0.81, 1.59), 2.29 (95% CI=1.10, 4.78), and 0.67 (95% CI=0.40, 1.14), respectively. The hazard ratios for cardiovascular disease mortality among cannabis users, compared with those among nonusers, were 1.65 (95% CI=0.57, 4.89) if the use was first initiated at age ≥18 years and 3.00 (95% CI=1.41, 6.38) if the use was first initiated before age 18 years. CONCLUSIONS: Cannabis use was significantly associated with an increased risk of cardiovascular disease mortality among U.S. adults, especially among those who started using cannabis before age 18 years. The reasons and mechanisms underlying this association will require future research.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Sun Y, Liu B, Wallace RB, et al. Association of Cannabis Use With All-Cause and Cause-Specific Mortality Among Younger- and Middle-Aged U.S. Adults. Am J Prev Med. 2020. PMID: 33220757. doi:10.1016/j.amepre.2020.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。